These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 26410808)
61. New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting. Chytil P; Etrych T; Konák C; Sírová M; Mrkvan T; Boucek J; Ríhová B; Ulbrich K J Control Release; 2008 Apr; 127(2):121-30. PubMed ID: 18304673 [TBL] [Abstract][Full Text] [Related]
62. Epirubicin loaded with propylene glycol liposomes significantly overcomes multidrug resistance in breast cancer. Zhao YZ; Dai DD; Lu CT; Chen LJ; Lin M; Shen XT; Li XK; Zhang M; Jiang X; Jin RR; Li X; Lv HF; Cai L; Huang PT Cancer Lett; 2013 Mar; 330(1):74-83. PubMed ID: 23186833 [TBL] [Abstract][Full Text] [Related]
63. Backbone degradable multiblock N-(2-hydroxypropyl)methacrylamide copolymer conjugates via reversible addition-fragmentation chain transfer polymerization and thiol-ene coupling reaction. Pan H; Yang J; Kopecková P; Kopecek J Biomacromolecules; 2011 Jan; 12(1):247-52. PubMed ID: 21158387 [TBL] [Abstract][Full Text] [Related]
64. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations. Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610 [TBL] [Abstract][Full Text] [Related]
65. Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells. Hongrapipat J; Kopecková P; Liu J; Prakongpan S; Kopecek J Mol Pharm; 2008; 5(5):696-709. PubMed ID: 18729468 [TBL] [Abstract][Full Text] [Related]
66. PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination. Satchi-Fainaro R; Hailu H; Davies JW; Summerford C; Duncan R Bioconjug Chem; 2003; 14(4):797-804. PubMed ID: 12862433 [TBL] [Abstract][Full Text] [Related]
67. A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo. Bahreyni A; Alibolandi M; Ramezani M; Sarafan Sadeghi A; Abnous K; Taghdisi SM Colloids Surf B Biointerfaces; 2019 Mar; 175():231-238. PubMed ID: 30537619 [TBL] [Abstract][Full Text] [Related]
68. In vitro and in vivo effect of HPMA copolymer-bound doxorubicin targeted to transferrin receptor of B-cell lymphoma 38C13. Kovár M; Strohalm J; Ulbrich K; Ríhová B J Drug Target; 2002 Feb; 10(1):23-30. PubMed ID: 11996083 [TBL] [Abstract][Full Text] [Related]
69. Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic. Duncan R; Gac-Breton S; Keane R; Musila R; Sat YN; Satchi R; Searle F J Control Release; 2001 Jul; 74(1-3):135-46. PubMed ID: 11489490 [TBL] [Abstract][Full Text] [Related]
70. HPMA copolymer-doxorubicin-gadolinium conjugates: synthesis, characterization, and in vitro evaluation. Zarabi B; Nan A; Zhuo J; Gullapalli R; Ghandehari H Macromol Biosci; 2008 Aug; 8(8):741-8. PubMed ID: 18484565 [TBL] [Abstract][Full Text] [Related]
71. A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy. Liu CW; Wu YT; Lin KJ; Yu TJ; Kuo YL; Chang LC Molecules; 2016 Jun; 21(6):. PubMed ID: 27258243 [TBL] [Abstract][Full Text] [Related]
72. Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery. Chang LC; Wu SC; Tsai JW; Yu TJ; Tsai TR Int J Pharm; 2009 Jul; 376(1-2):195-203. PubMed ID: 19439169 [TBL] [Abstract][Full Text] [Related]
73. Fucoidan based polymeric nanoparticles encapsulating epirubicin: A novel and effective chemotherapeutic formulation against colorectal cancer. Khan SH; Anees M; Zofair SFF; Rasool F; Khan MA; Moin S; Younus H Int J Pharm; 2024 Oct; 664():124622. PubMed ID: 39197799 [TBL] [Abstract][Full Text] [Related]
74. Combination cytotoxicity of backbone degradable HPMA copolymer gemcitabine and platinum conjugates toward human ovarian carcinoma cells. Duangjai A; Luo K; Zhou Y; Yang J; Kopeček J Eur J Pharm Biopharm; 2014 May; 87(1):187-96. PubMed ID: 24316339 [TBL] [Abstract][Full Text] [Related]
75. Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo. Jalalian SH; Taghdisi SM; Shahidi Hamedani N; Kalat SA; Lavaee P; Zandkarimi M; Ghows N; Jaafari MR; Naghibi S; Danesh NM; Ramezani M; Abnous K Eur J Pharm Sci; 2013 Oct; 50(2):191-7. PubMed ID: 23835028 [TBL] [Abstract][Full Text] [Related]
76. Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo. Lo YL; Liu Y; Tsai JC Biomed Pharmacother; 2013 May; 67(4):261-7. PubMed ID: 23540284 [TBL] [Abstract][Full Text] [Related]
77. Clinical experience with anthracycline antibiotics-HPMA copolymer-human immunoglobulin conjugates. Rihova B Adv Drug Deliv Rev; 2009 Nov; 61(13):1149-58. PubMed ID: 19682512 [TBL] [Abstract][Full Text] [Related]
79. Stimuli-responsive biodegradable and gadolinium-based poly[N-(2-hydroxypropyl) methacrylamide] copolymers: their potential as targeting and safe magnetic resonance imaging probes. Li X; Sun L; Wei X; Luo Q; Cai H; Xiao X; Zhu H; Luo K J Mater Chem B; 2017 Apr; 5(15):2763-2774. PubMed ID: 32264163 [TBL] [Abstract][Full Text] [Related]
80. Stimuli-Sensitive Biodegradable and Amphiphilic Block Copolymer-Gemcitabine Conjugates Self-Assemble into a Nanoscale Vehicle for Cancer Therapy. Duan Z; Zhang Y; Zhu H; Sun L; Cai H; Li B; Gong Q; Gu Z; Luo K ACS Appl Mater Interfaces; 2017 Feb; 9(4):3474-3486. PubMed ID: 28029039 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]